100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Human IL-2 Antibody [MQ1-17H12] (AGEL2041)

SKU AGEL2041
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Applications FC
$124 - $471

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human IL-2 Antibody [MQ1-17H12]

The Human IL-2 Monoclonal Antibody FITC Conjugated (MQ1-17H12) provided by AssayGenie (AGEL2041) is an essential tool for researchers studying interleukin-2 (IL-2) signaling pathways and immune responses in human cells. IL-2 is a key cytokine that regulates the proliferation and differentiation of T cells, playing a crucial role in immune system function. This monoclonal antibody, conjugated with FITC for fluorescent detection, specifically targets IL-2 molecules, allowing for precise and sensitive detection in various experimental settings.This antibody is highly specific to human IL-2, ensuring accurate and reliable results in applications such as flow cytometry, immunofluorescence, and immunohistochemistry. By targeting IL-2, researchers can investigate its involvement in immune cell activation, tolerance, and autoimmune diseases.

The conjugation with FITC enhances the visualization of IL-2-expressing cells, enabling detailed analysis of the cytokine's distribution and expression levels within biological samples.Furthermore, the AGEL2041 IL-2 monoclonal antibody facilitates the exploration of IL-2's role in immune disorders, infectious diseases, and cancer immunotherapy. Understanding the complex interactions involving IL-2 is instrumental in developing novel treatments and interventions for a range of health conditions. Researchers can confidently utilize this monoclonal antibody to delve deeper into the functions and implications of IL-2 in human biology, paving the way for innovative discoveries and advancements in immunology research.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose